Theoretical Estimation of \u3cem\u3epK\u3csub\u3ea\u3c/sub\u3e\u27s\u3c/em\u3e of Pyrimidines and Related Heterocycles by Wessner, Rachael Ann
Wright State University 
CORE Scholar 
Browse all Theses and Dissertations Theses and Dissertations 
2016 
Theoretical Estimation of pKa's of Pyrimidines and Related 
Heterocycles 
Rachael Ann Wessner 
Wright State University 
Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all 
 Part of the Chemistry Commons 
Repository Citation 
Wessner, Rachael Ann, "Theoretical Estimation of pKa's of Pyrimidines and Related Heterocycles" (2016). 
Browse all Theses and Dissertations. 1543. 
https://corescholar.libraries.wright.edu/etd_all/1543 
This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has 
been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE 
Scholar. For more information, please contact library-corescholar@wright.edu. 
 
 
Theoretical Estimation of pKa’s of 









A thesis submitted in partial fulfillment  
of the requirements for the degree of  







Rachael Ann Wessner 












Wright State University 
Graduate School 
June 1, 2016 
 
I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY 
SUPERVISION BY Rachael Ann Wessner ENTITLED Theoretical Estimation of pKa’s of Pyrimidines 
and Related Heterocycles BE ACCEPTED IN PARTIAL FULFILLMENT OF THE 




Paul G. Seybold, Ph.D. 
Thesis Director  
 
________________________ 
David A. Grossie, Ph.D. 
Department Chair  
 
















Robert E. W Fyffe, Ph.D. 
Vice President for Research and 








Wessner, Rachael Ann. MS., Department of Chemistry, Wright State University, 2016. 
Theoretical Estimation of pKa’s of Pyrimidines and Related Heterocycles.  
 
Pyrimidines and related heterocycles are an important class of compounds with a wide 
variety of applications. As a result, there is great interest in the chemical properties of these 
compounds, specifically their pKa’s. Despite the importance of these compounds their reported 
pKa’s are often only approximations or are completely absent from literature. Experimentally 
measuring pKa’s can be challenging, especially if the pKa is below zero. Alternatively, pKa’s can 
be estimated computationally using a Quantitative Structure-Activity Relationship (QSAR). 
However, most of the compounds included in this study exist as two or more forms that arise 
from tautomerism. Tautomerism complicates the estimation of pKa’s because proton transfers 
result in a rearrangement of electron density that alters chemical behavior. As a result, pKa’s are 
unique to each tautomeric species. This research identifies the most stable tautomer associated 
with each of the compounds included in this study. From here QSAR models have been 
constructed using a variety of molecular descriptors. The resulting QSAR models are then used 
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An Introduction to Pyrimidines and Related Heterocycles 
 
1.1 This research project 
This study aims to estimate the pKa’s of important pyrimidines and related heterocycles using 
quantum chemical methods. Chapter 1 introduces the compounds selected for this study and 
details their biochemical roles and applications. Most of these compounds can exist in a number 
of tautomeric forms, making it important to determine which forms prevail in both vacuum and 
aqueous solution. Accordingly, Chapters 2 and 3 chronicle the investigation of tautomer 
stabilities of uracils and cytosines, respectively.  
Chapter 4 describes the estimation of pKa’s for these compounds using a Quantitative 
Structure-Activity Relationship (QSAR) approach.1-3 This approach employs examination of a 
variety of quantum chemical descriptors for their correlation with experimental pKa’s. The 
change in energy ΔE between the parent and dissociated forms of the compounds is selected as 
the best quantum chemical descriptor for estimating the pKa
’s and used for this purpose.  
Previously unreported pKa’s are then estimated using this descriptor. Results obtained from the 
vacuum and SM8-water solvent model4 in the computational program Spartan’10 (Wave-
function, Inc., Irvine, CA) are compared with experimental data in order to establish the merits 
of this method.  
Pyrimidines form an important class of nitrogen-containing monocyclic aromatic 
compounds. Many pyrimidines are of interest in molecular genetics, neurological research, 
pharmaceutical development and other areas. However, despite their widespread applicability, 
the pKa’s of many pyrimidines and related compounds are not available. Determining accurate 
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dissociation constants is important because it allows the most stable chemical species of a 
compound at a particular pH to be identified.  
The following section briefly discusses the quantum chemical methods employed, and 
Section 1.3 discusses the solvent model. Section 1.4 reviews the roles and applications of the 
thirty one pyrimidines and related heterocyclic compounds examined in this study. 
1.2 An introduction to quantum chemical methods  
There are a variety of computational methods available, each presenting strengths and 
weaknesses. Semi-empirical methods are computationally inexpensive, but they are generally not 
suited for calculations that require high accuracy. In some cases semi-empirical methods can be 
used as a preface to more advanced calculations in order to decrease computational time. The 
Hartree-Fock method consistently overestimates the molecular energy because it does not 
account for electron correlation. Moller-Plesset5,6 perturbation theory is similar to the Hartree-
Fock method, but treats electron correlation energy as a perturbation. Configuration interaction is 
a variational method that is capable of accounting for electron correlation, but it is generally only 
applied to small molecules because it is computationally expensive. Density functional 
Theory7,8,9 (DFT) is different from other quantum chemical methods in that it works with the 
electronic probability distribution rather than the wave function itself. It is advantageous because 
it accounts for electron correlation while remaining relatively computationally inexpensive. 
Coupled Cluster10 calculations are currently considered the gold-standard of quantum chemical 
methods, but are extremely computationally demanding. 
In the computations used in the present work rough starting geometries were obtained using 
the semi-empirical method RM1.11 Density functional theory at the B3LYP/6-31+G** level was 
selected to further optimize the equilibrium geometries because it generally yields values 
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comparable to experimental data.12 The B3LYP functional is a widely-used functional within 
DFT theory.  The 6-31+G** basis set approximates each inner-shell Slater-type orbital with six 
Gaussian functions.13 Each valence atomic orbital is expanded as an inner and an outer Slater-
type orbital, which in turn are approximated with 3 and 1 Gaussian functions, respectively.13 
Diffuse functions (+) are added to each of the heavy atoms to account for dispersion of electron 
clouds, particularly in anions, and polarization functions (**) are added to both the heavy and 
light atoms to correct for ionic character.13  
1.3 An introduction to solvent models 
A solvent model was required because the experimentally determined pKa’s considered here 
were measured in aqueous solution. The use of a solvent model is expected to improve the 
correlation between quantum chemical descriptors and experimental pKa’s by accounting for 
solvation energy and other solvent effects. Accurate solvent models must include long distance 
polarization effects, short distance polarization effects and short distance electrostatic 
interactions such as hydrogen bonding.4  There are two main types of solvent models, referred to 
as implicit and explicit. Explicit solvent models account for solvent-solute interactions by 
incorporating discrete solvent molecules into the calculation.2, 14 This method is disadvantageous 
because it is very computationally demanding, while still failing to completely replicate all 
properties of aqueous solvation. Implicit solvent models are much less computationally 
demanding but lack the ability to directly account for discrete solvent-solute interactions. Instead, 
implicit solvent models include both macroscopic properties such as dielectric constant and bulk 
surface tension as well as microscopic properties such as polarizability and effective solvent 
radius.2 The SM8 solvent model4 (an implicit solvent model) was selected for this study because 
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it has been parametrized to reproduce experimental energies and has shown reasonable accuracy 
in previous studies.15-16   
1.4 Biochemical roles and applications of pyrimidines and related heterocycles   
This section reviews some of the biochemical roles and applications of pyrimidines and 
related heterocycles, and highlights the significant differences in chemical properties that can 
arise from small changes in chemical structure. These compounds have diverse medicinal uses 
and are found abundantly in nature. As a result, heterocyclic chemistry is an important area of 
study. Figure 1 shows the compounds that will be included in the pKa study, although, this 
























■ Nucleobases and the origin of life    
The pyrimidine moiety is most notably found in the nucleobases cytosine, thymine and 
uracil, which are key components of nucleic acids.17 The role of nucleobases in the origin of life 
has been heavily investigated and these compounds play a central role in modern genetics. Many 
studies have attempted to synthesize pyrimidine nucleobases and their complimentary purines 
under prebiotic conditions, but their presence on prebiotic earth is still debated.18-19 
In order for RNA to have contributed to the origin of life, as many theories suggest, the 
nucleobases and their complimentary purines must have been readily available on prebiotic 
earth.18 Cytosine is believed to have been synthesized from cyanoacetlyene and cyanate, and 
uracil can be formed if cytosine undergoes aqueous hydrolysis under mild conditions.18 Miller et 
al. demonstrated that the precursors required to synthesize cytosine and uracil are formed in 
abundance from the action of electric discharge on a gas mixture containing methane, ammonia 
and water.20 Although prebiotic earth did contain the reagents necessary to synthesize cytosine 
and uracil the conditions would have been far too extreme for spontaneous synthesis to occur,19 
and if cytosine was formed it would have most likely been consumed by deamination or other 
nucleophilic reactions.18  
However, small amounts of pyrimidines were extracted from the Murchison meteorite, 
which has led some scientists to conclude that a synthetic route must have been possible under 
prebiotic conditions.19 Robertson et al. proposed that cytosine could have been synthesized from 
cyanoaldehyde (formed from the hydrolysis of cyanoacetylene) and high concentrations of urea 
(released from lagoons).19 
Studies have also examined the prebiotic synthesis of purines to understand their 
relationship with early nucleobases. Guanine, which base pairs with cytosine, is the only purine 
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that has not been successfully synthesized. The inability to synthesize guanine under prebiotic 
conditions led to an investigation of Watson-Crick base pairing of cytosine with its structural 
isomer isocytosine.21 Accordingly, it has been theorized that isocytosine may have paired with 
cytosine in place of guanine in early nucleic acids.21 
■ Bioactive pyrimidines and related heterocycles   
Many pyrimidines and related heterocycles are biologically active compounds that are 
commonly used as constituents in pharmaceutical synthesis. Pyrimidine is easily modified to 
synthesize many diverse derivatives that are capable of targeting a wide-variety of 
biochemical pathways.22 For example, pyrimidine derivatives are known to exhibit 
many pharmacological properties including anticonvulsant, antibacterial, antiviral, antifungal, 
and antitumor activities.22 As a result, many drugs in this class have been listed on the World 
Health Organization’s list of essential medicines.  
Barbiturates (derived from barbituric acid) are a widely-used class of drugs that act on the 
central nervous system. These drugs have a wide range of activities 
including sedative, anesthetic and antiepileptic activities.17 
Phenobarbital is a common anti-seizure medication that expresses 
sedative properties. Pernocton was the first barbiturate to be used intravenously 
in anesthesia.23 Other barbiturates have been successful in the treatment of schizophrenia and 
anxiety.23 Barbiturates have also found use in pain management, but were 
eventually replaced by benzodiazepines because they carried a high risk of 
dependence and death by overdose.23 Some barbiturates, such as  pentobarbital, were so toxic 
that they were used in executions throughout the United States.23   
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Related heterocycles such as piperazine and isoxazole have found use in the treatment of 
Alzheimer’s disease. Alzheimer’s disease is estimated to affect approximately 26 million people 
worldwide and the search for a cure has proven difficult.24 A few compounds 
have been shown to help manage neurodegeneration and cognitive decline 
associated with Alzheimer’s disease. A piperazine containing drug known as 
4-(2-hydroxyethyl)-1-piperazinepropanesulphonic acid  (EPPS) has recently 
been shown to disaggregate toxic oligomers and plaques that have been linked to the early 
manifestation of Alzheimer’s disease.25 The transition of amyloid-beta monomers into toxic 
oligomers and plaques often precedes the development of clinical symptoms which intensifies 
the need for an agent capable of reversing their formation.25 Isoxazole containing 
drugs have also shown promise in the treatment of  treatment of Alzheimer’s disease 
by inhibiting  acetylcholinesterase.26 Acetylcholinesterase is the enzyme responsible for 
terminating the transmission of nerve impulses in cholinergic synapses.26 The treatment of 
Alzheimer’s disease currently focuses upon normalizing acetylcholine levels, so the ability to 
inhibit acetylcholinesterase might be a viable way to manage neurological symptoms.26  
 As previously mentioned, many pyrimidine based drugs are antimetabolites, because they 
are structurally similar to the endogenous substrates they antagonize.27 Antimetabolites can 
generally be categorized as nucleobase analogues, nucleoside 
analogues, nucleotide analogues and antifolates. 5-fluorouracil 
and thiouracil are examples of early pyrimidine derivatives that 
showed anticancer properties.27 Other common examples include trimethoprim, sulfadiazine and 
bleomycins which are used in chemotherapy.17 Succinimide has been shown to express 
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antimicrobial, antitumor and anti-inflammatory properties.28 Several derivatives of succinimide 
have recently been placed in clinical trials as candidates in the treatment of melanoma.28 
Some pyrimidine derivatives are also antibiotics. For example, aminoglycoside 
antibiotics like phleomycin and bleomycin are wide-spectrum antibiotics that contain the 
pyrimidine moiety.27 Bacimethrin is a pyrimidine derivative that is used to treat staphylococcal 
infections.27 The first sulfonamide antibacterial agent was a pyridine derivative known as 
sulfapyridine.17 Other sulfa drugs such as sulfadiazine and sulfadimidine are often used to treat 
urinary tract infections and cerebrospinal meningitis.27 Sulfa drugs are very important for people 
who are allergic to penicillin and for HIV positive patients that are prone to 
infections.27 The pyrimidine moiety is also found in a number of drugs that 
are used to treat hepatitis C, AIDS/HIV and herpes. Sovaldi, Harvoni and 
Dasabuvir are well-known antiviral agents used to treat hepatitis C. 
Azidothymidine and zidovudine are antiretroviral medications that are used to prevent 
HIV/AIDS.  
Other pyrimidine derivatives are known antifungals and antihelmintics. Flucytosine is a 
nucleoside antifungal that is used to treat systemic infections caused by exposure to 
Candida and  Cryptococcus fungi.27 Pyrantel pamoate is used to rid hosts of 
pinworms and roundworms by causing spastic paralysis to the worms.27 The 
pyridazine derivative maleic hydrazide is used as both a an anthelmintic and a herbicide.17  
■ Pyrimidines and related heterocycles in nature  
Pyrimidine rings and related heterocycles are also found abundantly in nature, and serve a 
variety of purposes. Pyrimidine-like rings are found most notably in the vitamin B complex, 
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chlorophyll, plant pigments, alkaloids, alarm pheromones in ants,17 amino acids and proteins, 
enzymes and DNA.26 Imidazole rings are found in the histidine residues of many 
proteins and enzymes and can act as natural buffers.17 Imidazole can also form 
complexes with many metal ions, perhaps the best-known, example being 
hemoglobin.17 Hemoglobin is a Fe (II)-complex of heme with the imidazole moiety of the amino 
acid histidine contained in the protein globin.17  
In nature, pyrrole rings are most commonly found as bilirubinoids (linear tetrapyrroles), 
porphyrins and corrins (cyclic tetrapyrroles).17 Bilirubinoids are formed 
when porphyrins are oxidized and commonly occur in vertebrates, 
invertebrates and algae.17 Porphyrins are composed of four pyrrole units 
connected by methine bridges at the α-carbons.17 Many key biomolecules 
such as hemoglobin and chlorophyll employ porphyrin-like moieties to chelate metal ions.17  
1-methypiperazine is a small heterocyclic compound found in variable concentrations on 
human skin.29 It is naturally produced in some individuals or it can be generated by bacteria that 
live on the skin.29 The presence of 1-methylpiperazine prevents mosquitoes from detecting the 
presence of the individual,29 and may explain why some people are more prone to mosquito bites 
than others.29   
Piperidine is found in the pituitary, pineal and adrenal glands of mammals.30 It is 
responsible for the release of acetylcholine, serotonin and pituitary hormones, which has led to  
its investigation as a modulator of the neuroendocrine system.30 Piperidine 
alkaloids are commonly found in plants such as pomegranates and palm tree 
seeds.17 The piperidine alkaloid coniine is the toxin found in poison 
hemlock.17 Isoxazoles have also been isolated from many natural 
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sources including insecticides, plant growth regulators and pigments.26 Isoxazole has also been 
identified as the active constituent in the psychotropic fly agaric mushroom.26 Paraquat and 
diquat are pyridine derivatives that show biological activity as herbicides. The herbicide 
difenzoquat and the insecticide dimetilan are also biologically active derivatives of pyrazole.17 
A similar heterocycle is found in creatinine, which is a small 
molecule related to renal function. Creatinine is a produced when high 
energy creatine phosphate is decomposed in muscle tissue.31 Healthy 
renal function is characterized by a constant expulsion of creatinine from the body by the 
kidneys.31 Accordingly, renal function is often assessed by measuring the level of creatinine in 
the blood, where an atypical level of creatinine in the blood stream indicates kidney problems.31   
5-methylcytosine is another important compound containing the pyrimidine moiety that 
has been heavily researched for its role in epigenetics. Epigenetics explains heritable changes in 
gene expression that are not the result of changes in DNA sequence. 5-
methylcytosine is formed when an enzyme in the methyltransferase family 
methylates the C5 position of cytosine.
32 Most tissues exhibit methylation 
patterns that are part of normal regulatory function. However, hypermethylation can result in 
silenced genes by inhibiting transcription factors from binding to affected DNA.32 The cause of 
atypical methylation is unknown, but it is believed to be linked to life experiences such as 
medication, exercise, diet and trauma.32 Atypical methylation has been linked to the onset of a 
variety of diseases including Alzheimer’s disease (AD), mental disorders, diabetes, and 
autoimmune diseases. For example, researchers discovered unusually high methylation levels in 
the entorhinal cortexes (primary site of manifestation in AD) of post mortem cohorts that were 
afflicted with AD.24 Another study found that consistent exercise could alter methylation 
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patterns, which explains why physical activity has long been prescribed as an effective treatment 






Analysis of Uracil Tautomers 
 
2.1 What are tautomers and why are they important in this study?  
Tautomerism (see, for example, Figure 2) refers to the transfer of a proton between two sites 
on a compound.34 It is important to recognize that tautomerism is not limited to neutral species; 
charged compounds also may exist in several ionic forms as well and these forms can also 
display tautomerism. As a simplification, the most stable ionic species can normally be attributed 
to protonation or deprotonation of the most stable neutral species. Accordingly, only ionic 
species derived from the most stable neutral species normally needs to be examined, which 
significantly reduces computational effort.  
 
Figure 2: An example of keto-enol tautomerism in maleimide. 
 
As discussed at greater length in Chapter 4, we define the pKa for dissociation of the 
cationic species of a compound to form the neutral species as pKa1, and that for dissociation of 
the neutral species to form the anion as pKa2. Consequently, identifying the most stable species 
of each type is necessary to correctly identify the dissociation reactions responsible for pKa1 and 
pKa2.  
Most of the compounds included in this study can exist as two or more tautomeric forms, 
both in vacuum and in solution. Dissociation constants and their positions are unique to each 
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tautomeric species because proton transfers result in a rearrangement of electron density that 
alters chemical behavior.35 In some cases literature reports fail to identify the tautomeric form 
associated with a particular dissociation constant, so care must be taken when assigning 
experimental pKa’s to compounds that exist in multiple forms. This chapter aims to identify the 
predominant form of each uracil-type species included in this study so that experimentally 
measured pKa’s can be accurately assigned. In addition, the physicochemical features that affect 
tautomeric stability will be analyzed in order to understand the relationship between tautomerism 
and chemical behavior.   
2.2 What factors influence the stability of a tautomer?  
The stability of a tautomer is dependent upon both structural features and environmental 
conditions. Stability is influenced by a number of factors including solute-solvent hydrogen 
bonding, medium polarity, and substituents. In the gas phase, i.e., vacuum, the energy Evac of a 
compound is often referred to as the intrinsic stability because external factors are absent. The 
intrinsic stability of each species can be used to assess the impact of solvation. Solvation energy 
(Eq. 1) is defined as the energy change ΔEsolv that arises when a compound is placed in a solvent 
yielding Esoln.  
                                                          ΔEsolv = Esoln – Evac                                         (1) 
The solvation energy ΔEsolv is the result of both Van der Waals and hydrogen bonding 
interactions that occur between solute and solvent molecules. In aqueous solution solutes that 
exhibit a more heterogeneous charge distribution will normally have a greater solvation energy 
because solvent molecules can more readily form strong local electrostatic interactions with 
them. In computational studies it is also important to recognize that solvation energy can be 
affected by a change in molecular geometry.                                                     
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Often the predominant tautomer is medium dependent as shown in Figure 3. In vacuum 
tautomers that exhibit homogeneous charge distributions are normally favored because 
sustaining charge differences requires energy. In aqueous solution forms that exhibit 
heterogeneous charge distributions can be lower in energy because of the formation of local 
associations with solvent molecules. Keto-enol tautomerism is particularly solvent dependent, 
largely due to electrostatic interactions. In vacuum or in nonpolar solvents enol forms are 
generally favored, but in aqueous environments, particularly under biological conditions, keto 
forms are usually preferred.35 In the example in Figure 3 compound B is more stable in vacuum, 
but because of a large solvation energy compound A is more stable in solution.  
 
Figure 3: Intrinsic and solvation energies of two tautomeric species. 
 
Substituent-induced alterations in electron density can also influence pKa1 and pKa2 
because the pKa depends on the most stable dissociating and dissociated tautomers.
35 The most 
stable cation (pKa1) is expected to form at the site with the most negative charge in the neutral 
species because the positive proton will be held more tightly there, and the most stable anion 
(pKa2) is expected to form at the site with the smallest negative charge because the positive 
proton will be more readily released. Figure 4 shows a tautomerism of uracil in vacuum and the 
relative stabilities of each form. If kf and kr are the forward and reverse reaction rate constants 
(Eq. 2), respectively, the equilibrium constant Keq is defined as kf/kr.  
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                                                                  𝑲𝒆𝒒 =
𝒌𝒇
𝒌𝒓
                                                                                 (2) 
 
 
0 kJ/mol                     74.4 kJ/mol 
Figure 4: An example of amine-imine tautomerism in neutral uracil and the relative energies of 
each form in vacuum. 
                     
The most stable tautomer is characterized by the lowest energy with respect to other 
comparable species. Some compounds may exhibit two or more almost equally stable tautomers 
in a particular environment. If several stable species are present their population ratios can be 
estimated using the Boltzmann distribution law (Eq. 3) where N1 and N2 are the populations of 
tautomers 1 and 2 and ΔE is their energy difference.  
                                                                                 
𝑵𝟐
 𝑵𝟏
 = 𝒆−𝜟𝑬/𝑹𝑻                                           (3) 
Hybridization plays a key role in the stability of tautomers, particularly in the relative stabilities 
of protonated heterocyclic imines and amines. Protonation of a heterocyclic ring imine is almost 
always more energetically favored than protonation of a heterocyclic ring amine because it 
preserves the aromaticity of the ring. Aromaticity is maintained because the lone pair on a 
neutral imine resides in a sigma sp2 orbital in the plane of the ring (Figure 5) and attachment of a 
proton here does not destabilize the pi system. The lone pair on a neutral amine resides in a 2pz 
orbital perpendicular to the ring and contributes to the pi system. Protonation of this orbital 
induces a hybridization change that results in a loss of aromaticity. In some cases compounds 
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may act as carbon acids to avoid protonation of the amine, which is a higher-energy 
transformation than carbon protonation (Figure 4).  
 
Figure 5: Two possible sites of protonation in pyrimidine showing the hybridization of each 
product. The cation on the right is more stable than the cation on the left. 
2.3 The importance of uracil and its derivatives  
Uracil is a nucleobase found in RNA that exhibits a pKa2 of ~9.42 under physiological 
conditions.36 In its canonical form uracil exists as a neutral diketo species that can form a base 
pair with adenine. The occurrence of rare uracil tautomers and derivatives in genetic material is 
believed to induce mutagenicity, specifically if the chemical modification drastically alters the 
pKa of base pairing protons 
36 Electron-withdrawing groups typically cause a decrease in pKa, 
and electron-donating groups usually raise the pKa.
37 In uracil derivatives the pKa’s of N1H and 
N3H are heavily dependent on the properties of the substituent bonded to C5.
38 The chemical 
nature of  C5 substituents often affects the pKa2 of N1H and N3H differently, making it difficult to 
experimentally establish whether dissociation to the anion occurs at N1H or N3H.
38  
2.4 Methods 
A list of possible neutral tautomers was generated for each of the compounds included in 
this study. The energy of each species was calculated in vacuum and in aqueous solution using 
the Spartan’10 computational software package (Wavefunction, Inc., Irvine, CA) and the SM8 
aqueous solution model. 4 The geometries were initially optimized using the semiempirical 
method RM111 and then further optimized using density functional theory at the B3LYP/ 6-
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31+G** level. The energy of each tautomer was recorded and expressed as a relative energy with 
respect to the most stable species of that charge. The energy of each ionic species (associated 
with the most stable neutral tautomer) was also calculated and expressed as a relative energy. 
These calculations allowed the species responsible for pKa1 and pKa2 to be identified. The natural 
charges on the heavy atoms (for the most stable neutral species) were also recorded to assist in 
the identification of the dissociating species.  
2.5 Results  
Uracil and each of its derivatives have three possible positions of protonation (pKa1) denoted 
N1, N3 and C5 (see Figure 6 for numbering scheme). 
 
Figure 6: Pyrimidine numbering scheme. 
The related compound azauracil has four possible positions of protonation known as N1, N3, C5 
and N6. All of the compounds examined in this study can dissociate at either N1 or N3. In each 
tautomer figure the lowest-energy form in vacuum is indicated by red font and the lowest-energy 
form in water is indicated by blue font. This color scheme is also employed in the natural charge 
figures. 
■ Uracil  
 Many experimental and theoretical studies have examined tautomerism in uracil, and the 
majority of researchers have agreed that uracil exists primarily as a diketo species. Electron 
diffraction studies conducted by Ferenczy et al.39 led to the conclusion that uracil primarily exists 
in the diketo form. Feyer et al.40 corroborated this finding through X-ray absorption and resonant 
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auger experiments. A theoretical study by Millefiori et al.41 calculated the relative stabilities of 
uracil tautomers in vacuum and in aqueous solution using coupled cluster (CCSD, CCSD(T)) and 
density functional theory (B97-1 and PBE1PBE functionals) and found that the diketo species is 
~53 kJ/mol more stable than other forms.  
The results obtained in the present calculations are in agreement with the conclusions 
drawn from these studies. A list of the relative B3LYP/6-31+G** energies can be found in Table 
1 along with the solvation energies of each species. The structure of each tautomer considered in 
this study can be found in Figure 7. Calculations showed that U-1 (diketo species) was ~74 
kJ/mol more stable than the other tautomers in vacuum. In aqueous solution the relative energy 
of U-1 remained ~70 kJ/mol more favorable despite the large solvation energy of U-4 because its 
intrinsic energy is much lower than that of U-4. The electrostatic potential surfaces (see Figure 8) 
show that U-4 has a somewhat more heterogeneous charge distribution than U-1, which helps 
explain the large solvation energy of U-4 shown in Table 1.  
 




Figure 8: Comparison of electrostatic potential maps of U-1 and U-4. 
               
The natural charges on the heavy atoms in U-1 are reported in Figure 9. Quantum 
chemical calculations show that the natural charge of N1 is less negative than the natural charge 
of N3 despite the proximity of the keto groups. Carbon 5 displays a negative charge making it an 
ideal position for protonation. Also notice that the charges on the keto oxygens become more 
negative in aqueous solution which may be due in part to enhanced contributions from a 
zwitterionic resonance form (Figure 10).15 
             
Figure 9: Natural charges on the atoms in U-1. 
 
Figure 10: Zwitterionic contribution to the structure of uracil. 
             
Both vacuum and aqueous solution calculations show that protonation should occur 
predominately at C5, which suggests that protonating a carbon is a lower-energy transition than 





carbon acid, but other compounds, such as pyrrole, are well known to be carbon acids in their 
cationic forms.42 Protonation is unlikely to occur at an amine because the resulting cations are 
much higher in energy.  
 
Figure 11: Low-energy cationic tautomers of uracil. 
  
 Calculations showed that uracil is most likely to dissociate at N1H (Figure 12) in vacuum 
because N1
- is ~57.7 kJ/mol more stable than N3
-. In the neutral diketo species, N1 carries a less 
negative natural charge than N3, which supports the conclusion that N1 is the primary site of 
dissociation (Figure 9). In aqueous solution a small amount of U--2 (~4 %) is also expected to 
form because U--2 has a significantly larger solvation energy (~329 kJ/mol) than U--1 (~279 
kJ/mol). The electrostatic potential maps (shown in Figure 13) of U--1 and U--2 show a more 
heterogeneous charge distribution of charge in U--2, which is indicative of a greater solvation 
energy.  
 Jang et al. 37 investigated anionic tautomerism in uracil using different quantum chemical 
methods and has obtained slightly different results. Initial equilibrium geometries were obtained 
using density functional theory (B3LYP/6-31+G*) and then further optimized using a higher 
level basis set (cc-pVTZ(-f)++). Vacuum calculations showed that the dissociation of N1H was ~ 
48-58 kJ/mol more favorable than dissociation of N3H, which is comparable to the results 
obtained in the present study. A continuous-solvation approach that involved numerically solving 
the Poisson-Boltzmann (PB) equation was used to calculate the ΔGsolv. In contrast to the present 
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study, Jang et al. found that dissociation at N3H was ~ 62-68 kJ/mol more favorable than 
dissociation of N1H.
37 Advanced Chemical Developments (ACD) also cites N3H as the primary 
site of dissociation in neutral uracil under physiological conditions. These differences can most 
likely be attributed to the differing methods employed by these studies. 
 
 
Figure 12: Low-energy anionic tautomers of uracil.  
 
Figure 13: Electrostatic potential maps of the anionic forms U--1 and U--2. 
 
Table 1: Relative energies and solvation energies of uracil tautomers. 
Neutral Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
U-1 0 -57.3 0 
U-2 74.4 -63.7 68.1 
U-3 76.7 -77.5 56.5 
U-4 80.2 -102.0 35.5 
U-5 81.7 -93.6 45.5 
U-6 89.4 -88.4 58.3 
Cationic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
U+-1 0 -327.6 0 
U+-2 42.2 -304.8 61.8 
U+-3 61.8 -316.3 42.2 
Anionic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
U--1 0 -279.4 0 






■ Azauracil  
The structures of the neutral azauracil tautomers considered in this study are shown in 
Figure 14. In both vacuum and aqueous solution AZ-1 was the lowest energy neutral tautomer of 
azauracil. As seen in Table 2 the other forms were too high in energy to be considered significant 
tautomers.  
 
Figure 14: Neutral azauracil tautomers. 
 
 The natural charges on the heavy atoms in AZ-1 are reported in Figure 15. In general, the 
most stable cation should form at the nitrogen with the greatest negative charge and the most 
stable anion should form at the nitrogen with the smallest negative charge. However, results 
suggest that in some cases natural charges alone do not accurately predict the propensity of a 
group to ionize. Natural charges can be useful in understanding ionization if other factors such as 
hybridization are equivalent. Natural charges can also provide insight into the changes in 
electronic distribution that occur as a result of solvation. Here again notice that the charges on 
the keto oxygens become more negative in aqueous solution and the charges on the amine 




Figure 15: Natural charges on the heavy atoms in AZ-1. 
 
In vacuum and in aqueous solution AZ+-1 (Figure 16) was significantly more stable than 
the other cationic tautomers because it is the only form that remains semi-aromatic (Table 2).   
 
Figure 16: Low-energy cationic tautomers of azauracil. 
 
 In vacuum a mixture of anionic species is expected to form because several low-energy 
positions for proton dissociation are available. Based upon the vacuum energies of the anion 
tautomers, N1H is expected to be the preferential site of dissociation (~94%), yielding AZ
--1 but 
smaller quantities (~6%) of AZ--2 are also expected to be present. In aqueous solution 
dissociation at N3H becomes more favorable because AZ
--2 has a significantly greater solvation 
energy than AZ--1. In vacuum the anion that exhibits the most homogeneous charge distribution 
is likely to be favored. However, in aqueous solution the anion that exhibits the most 
heterogeneous charge distribution should be more stable because solvent molecules can readily 
form local electrostatic interactions with local charged regions of the molecule. As a result, 
species with the more nonuniform charge distributions are expected to exhibit greater solvation 
energies (Figure 17). Molecular electrostatic potential maps (shown in Figure 18) can be used to 




2 (ΔEsolv ~ -272 kJ/mol). Notice that solvation energies are greater for ionic species than they are 
for neutral species because they have an increased capability to form strong associations with 
polar solvent (here H2O) molecules.  
 
Figure 17: Low-energy anionic tautomers of azauracil. 
 
Figure 18: Molecular electrostatic potential maps of AZ--1 and AZ--2. 
Table 2: Relative energies and solvation energies of azauracil tautomers. 
Neutral Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
AZ-1 0  -42.6 0 
AZ-2 49.3 -66.8 25.8 
AZ-3 76.3 -59.4 59.5 
AZ-4 82.8 -64.3 61.1 
AZ-5 111.1 -98.2 55.4 
AZ-6 149.3 -90.1 101.7 
Cationic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
AZ+-1 0 -340.2 0 
AZ+-2 57.1 -309.8 87.5 
AZ+-3 71.8 -313.5 98.5 
AZ+-4 79.0 -303.5 115.6 
Anionic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
AZ--1 0 -272.4 19.1 







■ 5-Bromouracil  
 Most literature reports indicate that 5-bromouracil exists primarily as a diketo species. 
Hanus et al.43 used Coupled Cluster (cc-pVTZ) calculations to investigate the relative stabilities 
of 5-bromouracil tautomers in vacuum and using a bulk water model and reported that the 
neutral diketo species was exclusively present. Hanus et al. also refuted the previous report by 
Hu et al. 44 that suggested Hartree-Fock (STO-3G) calculations carried out in a bulk water model 
predicted favorability of enolic species. The study by Hu et al. most likely indicated the presence 
of enolic species because its lower level of theory did not account for electron correlation. 
 The 5-bromouracil tautomers investigated in this study are shown in Figure 19. Table 3 
shows the relative B3LYP/6-31+G** energies of each tautomer in vacuum and in aqueous 
solution, as well as the solvation energy associated with each species. As seen in uracil, the 
neutral diketo species was significantly more stable than enolic species in both vacuum and 
aqueous solution. Solvation did not appear to have a significant effect on the relative energies of 
the tautomers as the order of stability remained largely the same. The results of these calculations 
indicate that the presence of enolic tautomers is unlikely given their much higher energies.  
 




The natural charges on the heavy atoms in BrU-1 are reported in Figure 20. Notice that 
the natural charge on N1 is less negative than the natural charge on N3. As seen in uracil, C5 
carries a significantly negative charge that makes it a good position for protonation. However, 
the natural charge on C5 in 5-bromouracil is less negative than that in uracil, possibly because the 
bromine donates electron density to the π-system.  
 
Figure 20: Natural charges on the heavy atoms in BrU-1. 
 
 Both vacuum and aqueous solution calculations indicated that protonation is most likely 
to occur at C5 (Figure 21). Protonation occurred predominantly at C5, despite the addition of 
bromine, which further supports that protonating a carbon is less energy-requiring than 
protonating an amine. Literature held no reports of carbon acid behavior in 5-bromouracil, which 
may be due to the exceptionally low pKa1. Often it is quite difficult to experimentally measure 
pKa’s that are in the negative region.   
 
Figure 21: Low-energy cationic tautomers of 5-bromouracil. 
 
In vacuum and in aqueous solution calculations suggest that dissociation is most likely to 
occur at N1H (Figure 22). In aqueous solution N3H is expected to dissociate in small quantities 
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(~3%). In contrast, Privat and Sowers have suggested that dissociation of N3H should be 
enhanced, with respect to uracil, because the bromine can stabilize N3
- through induction.36 Yet 
according to quantum chemical calculations N1 has a slightly less negative charge than N3 which 
should heighten dissociation because the positive proton will be more readily released (Figure 
20).  
 
Figure 22: Low-energy anionic tautomers of 5-bromouracil. 
  
Table 3: Relative energies and solvation energies of 5-bromouracil tautomers. 
Neutral Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
BrU-1 0 -54.8 0 
BrU-2 40.4 -58.1 37.0 
BrU-3 48.2 -61.3 41.6 
BrU-4 50.9 -75.7 30.0 
BrU-5 102.1 -80.4 76.5 
BrU-6 120.4 -119.4 55.7 
Cationic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
BrU+-1 0 -295.1 0 
BrU+-2 44.8 -308.1 42.1 
BrU+-3 55.0 -284.9 55.0 
Anionic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
BrU--1 0 -267.9 0 
BrU--2 57.4 -316.7 8.7 
 
■ 5-Chlorouracil  
Many studies have investigated tautomerism in 5-chlorouracil, using a variety of different 
experimental and computational techniques. A theoretical study by Lukmanov et al.45 used 
composite G3MP2B3 and density functional theory (TPSS) methods to examine tautomerism in 
5-chlorouracil. Results indicated that the diketo species is the most favorable form of 5-
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chlorouracil in both vacuum and an explicit (first solvation shell modeled with five H20 
molecules) implicit solvent model. However, florescence experiments by Suwaiyan et al. 46 have 
found evidence that enolic species of 5-chlorouracil may be present in minute concentrations at 
room temperature.  
 Figure 23 displays the neutral tautomers of 5-chlorouracil that were examined in this 
study. The relative energies of the tautomers and their associated solvation energies can be found 
in Table 4. Calculations showed that the diketo species (ClU-1) was significantly lower in energy 
than the other tautomers in both vacuum and aqueous solution. The enolic tautomers of 5-
chlorouracil are ~35 kJ/mol higher in energy than the diketo species which suggests that they are 
unlikely to contribute significantly to the neutral population.  
 
Figure 23: Neutral 5-chlorouracil tautomers. 
 
The natural charges on the heavy atoms in ClU-1 are reported in Figure 24. As for the 
previous compounds, the natural charge at N1 is less negative than the natural charge at N3. As 
seen in uracil, C5 carries a significant negative charge that makes it a good position for 
protonation. The chlorine at C5 is significantly less positive than the bromine in 5-bromouracil 
which indicates that chlorine is a much more electronegative than is bromine and it is less willing 
to share its outer shell electrons than bromine. Also notice that the natural charges on the keto 
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oxygens become more negative in aqueous solution because solute-solvent interactions provide 
additional support for charge delocalization.  
 
Figure 24: Natural charges on the heavy atoms in ClU-1. 
 
Chlorinating C5 produced results comparable to those observed in 5-bromouracil which is 
not surprising given their almost indistinguishable pKa2’s. As seen in 5-bromouracil, C5 was the 
preferential site of protonation in 5-chlorouracil. The energy required to protonate a carbon 
remained lower than that required to protonate an amine despite halogenation. The cationic 
population was dominated by ClU+-1 as shown in Figure 25. Again, no literature reports of 
carbon acid behavior in 5-chlorouracil were found.  
 
Figure 25: Low-energy cationic tautomers of 5-chlorouracil. 
 
 In vacuum N1H is expected to be the primary site of dissociation (Figure 26), because 
ClU--1 is considerably lower in energy than ClU--2.  As observed in 5-bromouracil, N1 exhibits a 
slightly less negative charge than N3 which supports the preference for dissociation at this 
position (Figure 24). In aqueous solution a mixture of anions was predicted, although ClU--1 still 
accounted for ~98% of the anionic population. It is worth noting that ClU--2 has a substantially 
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larger solvation energy than ClU--1 because it exhibits a much more heterogenious distribution of 
charge (Table 4). As previously pointed out, a large solvation energy can drastically increase the 
stability of a compound in aqueous solution. These results suggest that chlorinating C5 resulted 
in decreased dissociation of N3 with respect to uracil. However, Privat and Sowers have 
suggested that chlorinating C5 should result in enhanced ionization of the N3 proton.
36  
    
Figure 26: Low-energy anionic tautomers of 6-chlorouracil. 
 
Table 4: Relative energies and solvation energies of 5-chlorouracil tautomers. 
Neutral Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
ClU-1 0 -55.2 0 
ClU-2 39.9 -57.7 37.3 
ClU-3 48.0 -58.4 44.8 
ClU-4 51.3 -74.2 32.3 
ClU-5 84.9 -54.6 85.4 
ClU-6 102.8 -78.5 79.5 
Cationic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
ClU+-1 0 -312.9 0 
ClU+-2 31.3 -295.8 48.4 
ClU+-3 40.1 -320.2 32.8 
Anionic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
ClU--1 0 -263.7 0 
ClU--2 57.2 -317.1 3.9 
 
■ 5-Fluorouracil  
 The majority of research has concluded that 5-fluorouracil exists primarily as a diketo 
species. Munoz et al.47 have theoretically investigated tautomerism in 5-fluorouracil in vacuum 
and with explicit solvent models (20 and 30 H2O molecules) using B3LYP/6-31+G**(3df, pd), 
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B3LYP/DGDZVP, and MP2/6-31G**. Their study indicated that the diketo species of 5-
fluorouracil is the most stable tautomer both vacuum and with an explicit solvent model. Rastogi 
et al.48 measured the FT-IR and FT-Raman spectra of 5-fluorouracil and made peak assignments 
by comparing the experimental vibrational modes to those calculated using density functional 
theory (B3LYP/6-31++G(3df,pd)). This study found that 5-fluorouracil only exists as the diketo 
species in the solid state. 
The neutral tautomers of 5-fluorouracil considered in this study are introduced in Figure 
27. The relative energies of each tautomer as well as the associated solvation energies can be 
found in Table 5. Calculations showed that FU-1 is significantly more stable than the other 
tautomers in both vacuum and aqueous solution, despite the large solvation energy of FU-7. 
Given the much higher energies of enolic species, it is unlikely that they significantly contribute 
to the neutral population.  
 
Figure 27: Neutral 5-fluorouracil tautomers. 
 
The natural charges on the heavy atoms in FU-1 (Figure 28) are fairly consistent with 
those observed in the other halogenated uracil derivatives. Again, the natural charge at N1 is less 
negative than the natural charge at N3. However, in 5-fluorouracil C5 exhibits a positive charge 
which should decrease the likelihood of protonation occurring at that position. There is a 
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significantly more negative charge on the fluorine than observed on bromine or chlorine because 
fluorine inductively withdraws more electron density through the σ-system.  
 
Figure 28: Natural charges on the heavy atoms in FU-1. 
 
5-fluorouracil also behaved as a carbon acid (Figure 29), in both vacuum and aqueous 
solution, despite the slightly positive charge on C5. Again no reports of carbon acid behavior 
were found in literature.  
 
Figure 29: Low-energy cationic tautomers of 5-fluorouracil. 
 
In vacuum and in aqueous solution N1H was determined to be the primary site of 
dissociation. Again, quantum chemical calculations show that N1 carries a slightly more positive 
charge than N3 (Figure 30). However, in aqueous solution FU
--2 was only 6.1 kJ/mol higher in 
energy (due to a large solvation energy) which indicates that it accounts for ~8% of the anionic 
population. These results suggest that fluorinating C5 affects the anionic population ratios 
slightly more than the other 5-halouracils. Again, Privat and Sowers suggest that fluorinating C5 
should result in enhanced ionization of the N3 proton.
36 Studies by Jang et al. indicate that 5-
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fluorouracil behaves much like uracil in that dissociation of N1 is favored in vacuum, but not in 
solution.37  
    
Figure 30: Low-energy anionic tautomers of 5-fluorouracil. 
 
Table 5: Relative energies and solvation energies of 5-fluorouracil tautomers. 
Neutral Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
FU-1 0 -54.8 0 
FU-2 38.3 -59.3 33.8 
FU-3 47.6 -57.7 44.8 
FU-4 52.6 -71.6 35.8 
FU-5 107.6 -80.6 81.8 
FU-6 116.5 -120.5 50.8 
Cationic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
FU+-1 0 -324.2 0 
FU+-2 27.1 -310.7 40.6 
FU+-3 30.7 -329.7 25.2 
Anionic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
FU--1 0 -261.2 0 
FU--2 51.2 -306.3 6.1 
 
■ 5-Formyluracil 
The 5-formyluracil tautomers considered in this study are shown in Figure 31. Jang et al. 
has called attention to the presence of two low energy conformational isomers of 5-formyluracil. 
They found that FlU-1 is 21.6 kJ/mol more favorable in vacuum, but expresses a 22.1 kJ/mol 
lower solvation energy than FlU-2 leading to comparable energies in aqueous solution. In the 
present study, FlU-1 was determined to be 22.8 kJ/mol more stable in vacuum than FlU-2, but 
2.6 kJ/mol less favorable in solution due to a smaller solvation energy. A Boltzmann Distribution 
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showed that in aqueous solution FlU-1 comprises ~26% of the neutral population with FlU-2 
accounting for the remaining ~74% (Table 6). These results illustrate the importance of 
considering conformers because they can be surprisingly different in energy. The other neutral 
species were too high in energy to be significantly contributing tautomers. Conformers 
associated with high energy species were not considered for energetic reasons.         
 
Figure 31: Neutral 5-formyluracil tautomers. 
 
The natural charges on the heavy atoms in FlU-1 were reported in Figure 32. Notice that 
the natural charge at N1 is less negative than the natural charge at N3 despite the proximity of the 
keto groups. The addition of a formyl group places a negative charge on C5 and positive charge 
on C6. Also notice that the charges on the keto groups become more negative in aqueous 
solution. 
 




Despite steric crowding at C5, 5-formyluracil also behaved like a carbon acid. No 
literature reports were found noting this preference for protonating C5, rather than a nitrogen, in 
5-formyluracil. Yet in both vacuum and in aqueous solution FlU+-1 was determined to be the 
most stable cationic species by ~40 kJ/mol and ~22 kJ/mol, respectively (Figure 33). The other 
cationic species were considerably higher in energy which suggests that their populations will be 
quite small.  
 
Figure 33: Low-energy cationic tautomers of 5-formyluracil.  
 
In vacuum FU--1was the most stable anionic form of 5-formyluracil by ~18 kJ/mol 
(Figure 34). However, in aqueous solution a mixture of anionic species emerged with FlU--2 
assuming ~36% of the population. While these results demonstrate a clear preference for 
dissociation of N1H, they also show that the cis-conformation exhibits a much greater solvation 
energy even when ionized. Studies by Jang et al. also cite N1 as the primary site of dissociation 
because the formyl group stabilizes the N1 anion through resonance.
37 This finding is further 
supported by quantum chemical calculations that show a slightly more positive charge on N1 




Figure 34: Low-energy anionic tautomers of 5-formyluracil. 
 
Table 6: Relative energies and solvation energies of 5-formyluracil tautomers.  
Neutral Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
FlU-1 0 -60.7 2.59 
FlU-2 22.8 -86.2 0 
FlU-3 39.7 -66.7 36.2 
FlU-4 44.0 -70.0 37.3 
FlU-5 48.9 -99.9 12.3 
FlU-6 96.1 -108.7 50.8 
FlU-7 99.8 -97.7 65.4 
FlU-8 108.1 -125.1 46.3 
Cationic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
FlU+-1 0 -316.7 0 
FlU+-2 40.1 -333.7 23.1 
FlU+-3 77.0 -363.5 30.6 
FlU+-4 77.0 -363.0 30.2 
FlU+-5 55.3 -335.2 36.8 
Anionic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
FlU--1 0 -248.3 0 
FlU--2 18.7 -256.6 1.41 
FlU--3 65.3 -293.8 19.8 
FlU--4 96.0 -328.5 15.9 
 
■ 5-Nitrouracil  
This study found that NU-1 was the predominant species in both vacuum and aqueous 
solution (Table 7). The other neutral forms (Figure 35) were significantly higher in energy and 




Figure 35: Neutral 6-nitrouracil tautomers. 
  
The natural charges on the heavy atoms in NU-1 are reported in Figure 36. Notice that 
the natural charge at N1 is less negative than the natural charge at N3 as a result of the electron 
withdrawing nitro group. The addition of a nitro group places a negative charge on C5 and a 
positive charge on C6. Also notice that the charges on the keto groups become more negative in 
aqueous solution.   
 
Figure 36: Natural charges on the heavy atoms in NU-1. 
 
As observed with each of the uracil derivatives, 5-nitrouracil showed a strong preference 
for protonation at C5 which was previously unreported (Figure 37). In vacuum and in aqueous 
solution    NU+-1was at least ~40 kJ/mol more favorable despite steric crowding at C5. The other 




Figure 37: Low-energy cationic tautomers of 5-nitrouracil. 
 
Calculations showed a strong preference for dissociation at N1H (Figure 38) in both 
vacuum and in aqueous solution. Like a formyl group, a nitro group can stabilize N1
- by 
delocalizing charge through resonance which lends to the clear preference for dissociation at that 
position.37 This finding is strengthened by quantum chemical calculations that show a slightly 
more positive charge on N1 which is indicative of greater anionic stability (Figure 36). There is 
no evidence that the dissociation of N3H is enhanced in aqueous solution, despite its slightly 
larger solvation energy.  
 
Figure 38: Low-energy anionic tautomers of 5-nitrouracil. 
 
Table 7: Relative energies and solvation energies of 5-nitrouracil tautomers. 
Neutral Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
NU-1 0 -67.0 0 
NU-2 42.5  -75.0 78.8 
NU-3 44.9 -74.8 34.5 
NU-4 47.1 -39.8 37.1 
NU-5 80.7 -68.8 49.7 
NU-6 89.6 -54.7 102.0 
NU-7 93.1 -110.4 74.3 
NU-8 126.3 -131.7 61.5 
Cationic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
NU+-1 0 -324.5 0 
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NU+-2 33.3 -334.5 23.3 
NU+-3 66.3 -352.7 38.1 
Anionic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
NU--1 0 -238.9 0 
NU--2 73.8 -287.0 25.8 
 
■ Thymine  
 X-ray crystallography studies by Voet et al.49 have found that thymine exists primarily as 
a diketo species in the crystalline form. IR studies by Shugar et al. have also indicated that the 
diketo species of thymine is the only significant tautomer. A theoretical study by Rejnek et al.50 
investigated tautomerism in thymine using coupled cluster calculations CCSD(T) in both 
vacuum and in bulk water using molecular dynamics. This study also found that the diketo 
species was much more stable than any of the enolic forms. However, florescence studies by 
Morsy et al. 51 have yielded evidence that trace amounts of enolic species may exist.        
Figure 39 introduces the tautomers of thymine that were investigated in this study. The 
relative energies of the tautomers as well as their solvation energies can be found in Table 8. 
Calculations showed that T-1 (neutral diketo species) was the predominant tautomer in both 
vacuum and aqueous solution. The other tautomers are significantly higher in energy which 
indicates that they are unlikely to appear at significant concentrations. It is worth noting that in 
some cases enolic species do exhibit greater solvation energies than the diketo species. However, 
the diketo species remains lower in energy in aqueous solution, despite the large solvation 




Figure 39: Neutral thymine tautomers. 
 
The natural charges on the heavy atoms in T-1 are reported in Figure 40. Notice that the 
natural charge at N1 is less negative than the natural charge at N3 despite the proximity of the 
keto groups. The addition of a methyl group places a negative charge on C5 and a positive charge 
on C6. Also notice that the charges on the keto oxygens become more negative in aqueous 
solution.   
 
Figure 40: Natural charges on the heavy atoms in T-1. 
            
In vacuum and in aqueous solution T+-1 was the only significantly populated cationic 
form (Figure 41) of thymine. Again, literature has not reported carbon acid behavior in thymine 




Figure 41: Low-energy cationic tautomers of thymine. 
 
In vacuum dissociation of the neutral species occurred primarily at N1H (Figure 42) 
because T--1 was ~52 kJ/mol more stable than T--2. In aqueous solution calculations suggest a 
mixture of T--1 (~96%) and T--2 (~4%) due to the large solvation energy of T--2. Quantum 
chemical calculations showed that N1 carries a slightly more positive charge than N3 which also 
supports a preference for dissociation at N1H (Figure 38). However, Jang et al. cite N3 as the 
primary site of dissociation in thymine in both vacuum and aqueous solution.37.  
 
Figure 42: Low-energy anionic tautomers of thymine. 
Table 8: Relative energies and solvation energies of thymine tautomers. 
Neutral Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
T-1 0 -53.3 0 
T-2 79.0 -86.9 45.4 
T-3 80.5 -69.3 64.5 
T-4 81.7 -79.0 55.5 
T-5 85.8 -101.4 37.6 
T-6 96.8 -89.1 61.0 
Cationic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
T+-1 0 -303.3 0 
T+-2 33.4 -277.7 59.0 
T+-3 40.9 -300.9 43.4 
Anionic Rel. E Vac. kJ/mol Sol. Energy kJ/mol Rel. E Aq soln. kJ/mol 
T--1 0 -284.2 0 




Analysis of Cytosine Tautomers 
 
3.1 An introduction to cytosine  
The properties of cytosine are of fundamental biological and chemical importance.40 
Understanding the chemical behavior of cytosine can provide insight into the relationship 
between the presence of rare tautomeric forms and spontaneous point mutations.52 Normal 
Watson-Crick base pairing occurs between the canonical forms of pyrimidine nucleobases and 
their complimentary purines with the appropriate orientations.53 However, rare tautomers can 
form mutagenic base pairs by achieving an appropriate orientation with an incorrect purine.53 As 
a result the population ratios of parent nucleobases and their minor tautomeric forms have 
received much investigation. Unlike uracil, where a single (neutral diketo) species dominates, 
several low energy tautomers of cytosine are observed.52 As a result, there has been much debate 
as to which cytosine forms are predominant in a given medium.  
3.2 Methods  
The methods used for tautomer analysis have been described in detail in Chapter 2: 
Analysis of Uracil Tautomers. In this chapter attention is turned to the analysis of cytosine 
tautomers by employing the same protocol.  
3.3 Results 
■ Cytosine 
 An early theoretical paper53 by Katritzky and Karelson used AM1 computations coupled 
with a self-consistent reaction field solvent model to estimate the relative stabilities of cytosine 
tautomers. While this study was insightful, it neglected to investigate the impact of conformers 
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associated with low-energy tautomeric forms. Matrix isolation infrared studies have identified 
the presence of cytosine tautomers C-1, C-2 and C-4, (see below) with the hydroxy-amino (C-2) 
form having the highest concentration.54 Computational studies by Fogarasi55 and Kobayashi56 
have reported slight differences in the hierarchy of stability that are largely method-dependent. 
Fogarasi calculated the relative energies of cytosine tautomers using single point coupled cluster 
single and double (CCSD) energies at MP2 optimized geometries with double-zeta basis sets and 
reported that the order of energies was C-2 > C-4 > C-1. In contrast, Kobayashi calculated the 
relative energies of cytosine tautomers using density functional theory at the B3LYP/6-31+G 
level and reported that the order of stability was C-2 > C-1 > C-4.   
A recent study by Alonso et al.52 has identified the presence of five distinct forms of 
cytosine in the gas phase using LA-MB-FTMW spectroscopy. This study was one of the first to 
demonstrate the capability to not only distinguish tautomeric forms but also conformers. 
However, this study did not investigate the impact of solvation on the population ratio of the 
tautomers and conformers of cytosine. The present study aims to assess the impact of solvation 
upon low-energy tautomers/conformers.   
The structures of the neutral cytosine tautomers/conformers considered are shown in 
Figure 43. Notice that the enolic protons are oriented towards the lone pair on the adjacent 
nitrogen due to electrostatic attraction. The present calculations (Table 9) show that several 
neutral species exist in vacuum with C-1 in the highest concentration (~58%). Minor contributors 
included C-2 (~31%), C-3 (~8%) and C-4 (~3%). Calculations suggested a clear preference for 
C-1 in aqueous solution due to its large solvation energy. The electrostatic potential maps 
(Figure 44) show that C-1 has a much more uneven charge distribution than C-2 which explains 
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its larger solution energy. The other neutral species were significantly higher in energy which 
indicates that they are unlikely to exist in significant quantities.  
 
Figure 43: Neutral cytosine tautomers. 
         
Figure 44: Molecular electrostatic potential maps of C-1 and C-2. 
 
Regarding the cationic tautomers of cytosine the present calculations predict a mixture of 
C+-1 (~62%) and C+-3 (~38%) in vacuum because C+-1 is just 1.5 kJ/mol lower in energy than 
C+-3 (Figure 45). In aqueous solution favorability shifts towards C+-3 because it has a larger 
solvation energy than C+-1. The other cationic species were much higher in energy which 
suggests that they are unlikely to exist in significant quantities. Notice that in the lowest-energy 
conformations enolic protons are oriented away from protonated imines due to electrostatic 





Figure 45: Low-energy cationic tautomers of cytosine.  
 
Figure 46: Dominant anionic form of cytosine. 
  
Table 9: Relative energies and solvation energies of cytosine tautomers. 
Neutral Rel. E. kJ/mol (Vac.) Solv. E. kJ/mol Rel. E. kJ/mol (Aq. Soln) 
C-1 0 -91.0 0 
C-2 1.60 -69.9 92.6 
C-3 4.85 -71.5 24.3 
C-4 7.70 -55.3 43.4 
C-5 15.5 -53.6 52.9 
C-6 29.2 -99.4 20.9 
C-7 56.7 -54.7 93.0 
C-8 78.3 -73.2 96.1 
Cationic Rel. E. kJ/mol (Vac.) Solv. E. kJ/mol Rel. E. kJ/mol (Aq. Soln) 
C+-1 0 -263.5 21.4 
C+-2 36.7 -274.3 47.2 
C+-3 1.5 -286.3 0 
                    
■ Flucytosine  
In flucytosine a fluorine atom is substituted on carbon 5. As observed in cytosine, several 
low-energy tautomers (Figure 47) of flucytosine were present in vacuum (Table 10). The 
majority of the population consisted of FC-1 (~76%) but small quantities of FC-2 (~17%) and 
FC-3 (~7%) were also estimated to be present. In aqueous solution the neutral population was 
composed predominantly of FC-3 because it exhibits a much greater solvation energy than the 
other forms. Figure 48 shows the electrostatic potential maps of FC-1 (most stable form in 
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vacuum) and FC-3 (most stable form in water). As expected the electrostatic potential map of 
FC-3 displays a more uneven charge distribution than FC-1 which is indicative of a greater 
solvation energy.  
 
Figure 47: Neutral flucytosine tautomers. 
 
Figure 48: Molecular electrostatic potential maps of FC-1 and FC-3. 
 
 A Boltzmann Distribution showed that FC+-1 was the only significant protonated species 
of flucytosine in vacuum (Figure 49). In aqueous solution there was a strong shift towards FC+-3 
but miniscule amounts of FC+-1 (~2%) may still be present. The formation of FC+-4 is extremely 
unlikely because protonating N1 severely distorts the planarity of the ring. Figure 50 shows the 





Figure 49: Low-energy cationic tautomers of flucytosine. 
 
Figure 50: Dominant anionic form of flucytosine. 
 
Table 10: Relative energies and solvation energies of flucytosine tautomers. 
Neutral Rel. E. kJ/mol (Vac.) Solv. E. kJ/mol Rel. E. kJ/mol (Aq. Soln) 
FC-1 0 -58.8 11.2 
FC-2 3.73 -70.0 12.8 
FC-3 5.54 -76.1 0 
FC-4 14.4 -47.6 36.8 
FC-5 38.7 -87.2 21.6 
FC-6 55.8 -50.3 75.4 
FC-7 85.8 -73.3 82.5 
Cationic  Rel. E. kJ/mol (Vac.) Solv. E. kJ/mol Rel. E. kJ/mol (Aq. Soln) 
FC+-1 0 -264.7 9.67 
FC+-2 37.9 -276.8 35.4 
FC+-3 11.47 -285.8 0 
 
■ Isocytosine  
 In vacuum a mixture of IC-1 (~91%) and IC-2 (~9%) were calculated to be present 
(Figure 51, Table 11). An experimental study reported that in vacuum isocytosine primarily 
exists as IC-1, but suggests that low concentrations of IC-2 may be present.57 Calculations 
showed that in aqueous solution the majority of the population is IC-5 (~60%) with smaller 
contributions from IC-2 (~38%) and IC-1 (~2%). Figure 52 shows the electrostatic potential 
maps of IC-1 and IC-5. Solvent molecules can more easily form local associations with IC-5 than 
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with IC-1 because it exhibits a more uneven charge distribution. Thus the relative stability of IC-
5 is enhanced in aqueous solution.  
 
Figure 51: Neutral isocytosine tautomers.  
 
Figure 52: Molecular electrostatic potential maps of IC-1 and IC-5. 
 
In vacuum the cationic population were estimated to consist of a mixture of IC+-1 (~70%) 
and IC+-3 (~30%) due to an energy difference of just ~3 kJ/mol (Figure 53). However, in 
aqueous solution IC+-3 is the predominant tautomer because it had a much greater solvation 





Figure 53: Low-energy cationic tautomers of isocytosine. 
 
Figure 54: Dominant anionic form of isocytosine. 
Table 11: Relative energies and solvation energies of isocytosine tautomers. 
Neutral Rel. E. kJ/mol (Vac.) Solv. E. kJ/mol Rel. E. kJ/mol (Aq. Soln) 
IC-1 0 -52.2 8.65 
IC-2 5.34 -65.1 1.14 
IC-3 19.7 -65.4 15.2 
IC-4 30.6 -54.0 37.4 
IC-5 48.3 -109.2 0 
IC-6 91.1 -79.4 72.6 
IC-7 130.5 -83.0 108.4 
Cationic (2a-4e-IC) Rel. E. kJ/mol (Vac.) Solv. E. kJ/mol Rel. E. kJ/mol (Aq. Soln) 
IC+-1 0 -282.7 13.8 
IC+-2 12.6 -268.9 40.4 
IC+-3 2.19 -306.8 0 
 













Theoretical Estimation of pKa’s 
 
4.1 An introduction to pKa’s and the value of computational estimation 
Acid dissociation constants are important because they identify the most stable chemical 
species of a compound at a particular pH. Determining the dominant chemical species is useful 
because molecular characteristics can be used to predict chemical behavior. Computationally 
estimating pKa’s is valuable because it circumvents many of the difficulties presented by 
experimental measurement of pKa’s.
1 The pKa for dissociation of the cationic species of a 
compound to form the neutral species is defined as pKa1, and that for the dissociation of the 
neutral species to form the anion is defined as pKa2 (Eq. 1). The acid dissociation constant Ka 
refers to the ratio of the proton dissociation products to that of the acid reactant (Eq. 2). The Ka 
can be used to determine the pKa of dissociation using Eq. 3. The change in Gibbs free energy at 







pKa = -log10 (Ka) = pH + log 
[𝑨−]
[𝐇𝐀]
                             (3) 
ΔE  ≈ ΔG˚ = 2.303 RT pKa  (4)  
A compound’s acidity (pKa) is dependent upon the stability of its conjugate base because 
dissociation is more likely to occur if the resultant anion is stable. Increasing the stability of the 
conjugate base increases the acidity of the conjugate acid (lowers pKa). Likewise, decreasing the 
stability of the conjugate base will decrease the acidity of the conjugate acid (raises pKa). Figure 
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55 shows the conjugate acid-base pairs of aziridine for both the cationic to neutral dissociation 
(pKa1) and the neutral to anionic dissociation (pKa2). A compound’s acidity can be influenced by 
several factors that will be discussed in the subsequent paragraphs. 
 
Figure 55: Conjugate acid-base pairs of aziridine associated with pKa1 and pKa2. 
 
Inductive effects can influence acidity by modifying the electron density at the site of 
dissociation through the σ-framework. Electron withdrawing substituents tend to decrease pKa by 
diminishing electron density at the dissociation site, while electron donating groups increase pKa 
by increasing electron density at the dissociation site.  
Resonance also plays a key role in acidity by providing a mechanism for charge 
delocalization through the π-system. The magnitude of the. 
 resonance effect is generally proportional to the number of resonance structures that a 
compound can adopt. Compounds that have many resonance structures are generally more stable 
than compounds that have few or no resonance structures. For example, unsaturated compounds 
that resonate will generally exhibit lower pKa’s than their saturated analogs because electron 
density can be delocalized about the π-system. Aromatic compounds are especially stable 
because conjugated π-electron systems efficiently delocalize charge throughout the molecule. 
Hyperconjugation is a distinct type of resonance that arises from alkyl moieties such as methyl 
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groups. Methyl groups are sp3 hybridized which gives rise to three-dimensional interactions 
involving the π system. The out-of-plane component of these sigma bonds donates electron 
density to the π-electron system through hyperconjugation which results in increased basicity.   
Theoretical pKa values can be calculated using a variety methods. The first principles 
approach uses thermodynamic cycles because they offer an energetic pathway from the reactants 
to the final products and include thermodynamic state functions.1 The first principles approach is 
useful because it is independent of associated experimental data, such as the pKa’s of related 
compounds.1 However, it is very computationally demanding and dependent on accurate solvent 
models, and is therefore often impractical.1 Advanced Chemical Development, Inc. (ACD) has 
also developed a method for computationally estimating pKa’s. ACD employs a fragment based 
approach to estimating pKa’s in which segments of compounds are assigned Hammett constants. 
The fragments and their corresponding Hammett constants are then compiled to form a database. 
A pKa can then be estimated for any compound that contains fragments reported in the database. 
However, this method can be problematic if the database is not coded for a fragment contained in 
the compound of interest.  
Quantitative Structure-Activity Relationships (QSARs) are a widely applicable modeling 
method that can be adapted to estimate pKa’s. This study will use QSAR modeling to estimate 
the pKa’s of important compounds that are not currently reported in the literature. To do this, 
quantum chemical calculations are first performed and useful molecular descriptors Xi are 
identified. Molecular descriptors are features that correlate with the propensity of a molecule to 
undergo some behavior, in this case to dissociate at a particular pH. In a group of related 
compounds, molecular features are expected to alter the Gibbs free energy G˚ of a compound in 
a consistent fashion. The merit of each molecular descriptor is determined through a linear 
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regression analysis, which correlates Xi with variations in the experimentally observed pKa’s 
(Eq. 5, where Ci is the coefficient of Xi).  
                                               pKa = Co + C1X1 + C2X2 + C3X3 + ….                         (5) 
While QSAR modeling does rely on the compilation of experimental data, such as pKa’s, it 
requires significantly less computational effort than the aforementioned first principles 
methodology.  
4.2 Methods 
 Experimental pKa’s were collected from literature sources for each compound. However, 
experimental pKa’s were unavailable for several of the compounds. These pKa’s will be 
estimated in this study. Additionally, pKa’s calculated by Advanced Chemical Development’s 
commercial program were determined for comparison purposes. Experimentally determined 
ΔG’s (for dissociation of the neutral species) were obtained from the NIST database58 for 6 
compounds.  
The following calculations were repeated for the most stable tautomer of each charge (as 
determined in Chapters 2 and 3) in vacuum and in aqueous solution. Quantum chemical 
calculations were performed using the Spartan’10 computational software package (Wave-
function, Inc., Irvine, CA) with and without the SM8 aqueous solution model.4 A rough 
equilibrium geometry of each compound was first obtained using the RM1 semiempirical 
method.11 The equilibrium geometry of each compound was then further optimized using density 
functional theory at the B3LYP/ 6-31+G** level. A series of quantum chemical descriptors was 
selected that included natural charges, Löwdin bond lengths, bond orders and the energy 
difference (ΔE) between the dissociating acid species and its dissociated species. The ΔE’s 
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associated with the dissociation reactions of pKa1 and pKa2 were examined in both vacuum and in 
aqueous solution.  
A linear regression analysis was performed on each correlation to ensure statistical 
soundness. The statistics examined included the correlation coefficient R, the coefficient of 
determination R2, the standard deviation s, and the Fisher Statistic F. The correlation coefficient 
R indicates the extent to which variations in experimental pKa values and the targeted molecular 
descriptor Xi coincide. The correlation coefficient ranges from -1 to 1, where the highest and 
lowest values are the most statistically significant.1 The coefficient of determination R2 indicates 
the fraction of the variance in the experimental pKa’s that is accounted for by the linear free 
energy relationship (LFER) equation.1 The coefficient of determination ranges from 0 to 1, 
where 1 would indicate a perfect correspondence. The standard deviation is a measure of the 
average uncertainty in the calculated pKa and should be as small as possible. The Fisher Statistic 
gives a measure of how well the model performs for a given number of descriptors.1 The Fisher 
Statistic should be as large as possible with the fewest number of descriptors possible used in the 
linear regression model. 
4.3 Results 
■ Literature compilation 
  Table 12 shows the compounds selected for this study, their chemical formulas, 
experimentally measured pKa1/pKa2 values and ACD-calculated pKa1/pKa2 values. Compounds 
for which pKa’s are currently unreported are indicated by a dash. The pKa’s of these compounds 
will be estimated in this study. N/A indicates compounds for which a nitrogen acid  pKa does not 
apply. Note that pyrrole and uracil and its derivatives were found to act as carbon acids (pKa1) so 
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they were excluded from the pKa regressions because carbon acids are not expected to behave in 
the same way as nitrogen acids. 




# Compound Formula pKa1 ACD pKa1 pKa2 ACD pKa2 
1 azauracil C3H3N3O2 - -4.4± 0.2 - 7.8 ± 0.2 
2 aziridine C2H5N 7.9859, 8.0560 8.1 ± 0.2 - - 
3 creatinine C4H7N3O 4.861   4.8 ± 0.1 - - 
4 cytosine C4H5N3O 4.3260, 4.5862, 4.661 4.4 ± 0.1 1360, 12.1562-63 12.3 ± 0.1 
5 flucytosine C4H3FN2O2 3.2661 2.6 ± 0.1 - 10.5 ± 0.1 
6 imidazole C3H4N2 7.1560, 6.99361-62 7.2 ± 0.6 14.4460 13.9 ± 0.1 
7 1-methylimidazole C4H6N2 6.9561 7.0 ± 0.1 N/A - 
8 4-methylimidazole  C4H6N2 7.5562 7.7 ± 0.6 - 14.3 ± 0.1 
9 isocytosine C4H5N3O 4.0161 3.4 ± 0.5 9.4263 9.6 ± 0.4 
10 isoxazole C3H6NO -2.061 -2.0 ± 0.5 N/A  
11 maleimide C4H3NO2 - -5.7 ± 0.2 9.564 8.5 ± 0.2 
12 morpholine  C4H9NO 8.49262 9.0 ± 0.2 N/A - 
13 piperidine  C5H11N 11.1262 10.4 ± 0.1 - - 
14 piperazine C4H10N2 9.7862, 9.7361 9.6 ± 0.1 - - 
15 1-methylpiperazine C5H12N2 10.1962 9.3 ± 0.1 - - 
16 oxazole C3H6NO 0.861 1.0 ± 0.1 N/A - 
17 pyrazine C4H4N2 0.6561 1.2 ± 0.1 N/A - 
18 pyrazole C3H4N2 2.6162 2.8 ± 0.1 14.2160 14.0 ± 0.5 
19 pyridazine  C4H4N2 2.359 3.1 ± 0.1 N/A - 
20 pyridine C5H5N 5.2361 5.2 ± 0.1 N/A - 
21 pyrimidine C4H4N2 1.359 1.8 ± 0.1 N/A - 
22 pyrrole C4H5N -3.861 -0.3 ± 0.5 17.060 17.0 ± 0.5 
23 pyrrolidine C4H9N 12.1060, 11.3161-62 10.5 ± 0.1 - - 
24 succinimide C4H5NO2 - -4.4 ± 0.2 9.6261-62, 9.6863 9.6 ± 0.1 
25 thymine C5H6N2O2 - -4.1 ± 0.4 9.960, 9.7962, 9.4461 9.2 ± 0.1 
26 uracil C4H4N2O2 - -4.2 ± 0.1 9.4336, 9.4561, 63 8.9 ± 0.1 
27 5-bromouracil C4H3BrN2O2 - - 7.9136 6.8 ± 0.1 
28 5-chlorouracil  C4H3CIN2O2 - - 7.9236 6.8 ± 0.1 
29 fluorouracil C4H4FN3O - - 8.0460, 8.0065, 7.9336 6.7 ± 0.1 
30 5-formyluracil  C5H4N2O3 - - 6.8436 7.3 ± 0.1 
31 5-nitrouracil C4H3N3O4 - - 5.336 5.2 ± 0.1 
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■ An investigation of the adequacy of the B3LYP/6-311+G** model. 
Equations 7 and 8 below show the Gibbs Energy associated with the dissociation of a 
neutral species (pKa2). However, the G difference between the neutral acid (HA) and anion (A
-) 
does not account for the ΔG of the mole of dissociated protons (H+). Accordingly, the ΔG of a 
mole of dissociating protons was determined to be 23.6 kJ/mol through a derivation that is shown 
in the appendix of this chapter. Note that NIST only lists experimentally measured ΔG’s for six of 
the compounds included in this study (Table 13).  
                                         ΔG° = G°products – G°reactants                                              (7) 
                                     ΔG° = (G°anion + G°proton) – G°neutral                          (8) 
 
Table 13: Experimental and calculated ΔG’s.  
Compound Exp. ΔG° a Calc. ΔG° b Calc. ΔE b 
pyridine -1601.0 -1631.9 -1647.9 
pyridine -1604.6 -1631.4 -1642.5 
pyrazine -1576.5 -1604.8 -1613.8 
pyridazine -1562.0 -1588.0 -1600.9 
imidazole -1433.4 -1458.4 -1466.2 
succinimide -1414.0 -1426.9 -1436.4 
a From  the NIST database58 
b B3LYP/6-31+G** 
 
 The correlation between experimentally measured vacuum ΔGs and theoretically 
calculated ΔGs for the dissociation reactions (Figure 56) was examined to evaluate the merit of 
the B3LYP/6-31+G** computational level, and the following correlation was obtained: 
                                ΔGrxn (exp.) = 0.94 (± 0.02) ·∆Grxn (calc.) – 64 (± 34)      (9) 




Correlation of the calculated vacuum Gibbs Energies with the experimental results yielded a 
standard deviation of s = 4.18 kJ/mol, a value close to the average experimental uncertainty. In 
addition, the Fisher statistic (F = 2344) was high, which indicates a good computational model. 
The coefficient of determination was exceptionally high (R2 = 0.998), indicating that the vacuum 
quantum chemical calculations closely correlated with the experimental measurements. The 
linear regression analysis verified that this level of computation is more than adequate to 
reproduce experimental data.  
 
 
Figure 56: Plot of experimentally measured ΔG°’s vs. theoretically calculated ΔG°vac’s for pKa2.  
■ Why is ΔE a good quantum chemical descriptor for pKa?  
 The ΔG° cannot be calculated in aqueous solution because solute-solvent interactions 
prevent the calculation of vibrations and rotations. Identifying a ΔG° surrogate that can be 
calculated in aqueous solution would prove to be a computational asset. Substituting ΔE for ΔG° 
is a common practice because ΔE can be more easily calculated. In addition, ΔE can be 
calculated using a solvent model like SM8 that can correct for solvation energy. The ΔE is often 
used as an approximation of ΔG° which is related to pKa by Equation 10.  



























Theoretical ΔG° vac's kJ/mol
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                                                            ΔE  ≈ ΔG˚ = 2.303 RT pKa                                     (10) 
Experimentally measured ΔG°’s associated with the dissociation of a neutral species to form an 
anionic species and a proton were collected from NIST58 and compared to theoretically 
calculated ΔE’s (Table 13) and the following linear regression is shown in equation 11. 
                                        ΔEpKa2 (calc.) = 1.08(± 0.02) · ΔG°pKa2 + 88 (± 37)              (11) 
n = 6, r2 = 0.999, s = 3.47 kJ/mol, F = 3021 
 
Experimentally measured ΔG°’s showed an excellent correlation (R2= 0.999) with theoretically 
calculated ΔE’s (Figure 57). In addition, the fisher statistic was extremely high (F=3021) and the 
standard deviation (s = 3.47 kJ/mol) was relatively low.  
 
 
Figure 57: Plot of theoretical ΔEvac’s vs. experimental ΔG°’s for pKa2.  
 
These results indicate that ΔE is a suitable substitute for ΔG° which significantly 
simplifies the theoretical estimation of pKa’s. Although the model was only tested in vacuum it is 
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reasonable to expect that ΔE would also be a valid surrogate for ΔG° in conjunction with a 
solvent model.  
 It was of interest to see if the vacuum E values for the dissociations could be used to 
approximate the solution pKa’s.  Accordingly, linear regressions (Figures 58 and 59) were 
constructed using experimentally measured aqueous pKa’s and theoretically calculated ΔEvac’s 
for pKa1 and pKa2. The regression equations and the related statistics for pKa1 and pKa are shown 
in equations 12 and 13, respectively: 
                                        pKa1 (calc.) = – 0.08 (± 0.01) ·∆Evac – 66 (± 11)                    (12) 
n = 20, R2 = 0.707, s = 2.18 F = 43.6 
 
                                      pKa2 (calc.) = – 0.0592 (± 0.007) ·∆EAq – 75 (± 10)                 (13) 
n = 13, R2 = 0.874, s = 1.17 F = 76.8 
 
The correlations obtained were only modest because the ΔE of the isolated molecules 
does not account for the role of the solvent in affecting the pKa’s in water. The experimentally 
determined aqueous pKa’s are affected by solute-solvent interactions that need to be accounted 
for by using a solution model. Other quantum chemical descriptors such as charges, bond lengths 




Figure 58:  Plot of experimental pKa1’s vs. theoretical ΔEvac’s. 
 
 
Figure 59: Plot of experimental pKa2’s vs. theoretical ΔEvac’s. 
■ Employing the SM8 aqueous solution model to account for the solvation energy 
The quantum chemical calculations were repeated using the SM8 solvent model4 in an 
effort to obtain a better correlation with experimental pKa’s by accounting for solvent effects on 
the pKa’s. The SM8 solvent model accounts for solvation energy by employing a dielectric field 
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to implicitly model solute-solvent interactions. A linear regression (Figure 60) was constructed 
using the ΔEAq for the dissociation of the cation to the neutral species plus a proton and 
experimentally measured pKa1’s. This resulted in a considerably improved coefficient of 
determination (R2= 0.965). The linear regression and related statistics are shown in equation 14. 
                                      pKa1 (calc.) = – 0.131 (± 0.008) ·∆EAq – 151 (± 10)                    (14) 
n = 18, R2 = 0.965, s = 1.25, F = 145 
 
The merit of this computational model was further corroborated by a good Fisher statistic 
(F= 145) and relatively low standard error (s = 1.25). This suggests that the SM8 solvent model 
corrects for a large portion of the error observed in the vacuum model by accounting for 
solvation energy.  
 
 
A linear regression (Figure 61) was also constructed to model the relationship between 
ΔEAq for dissociation of a neutral species and the experimentally measured pKa2’s, and the 
following linear regression and related statistics are shown in equation 15. 
                                     pKa2 (calc.) = – 0.141 (± 0.008) ·∆EAq – 159 (± 10)                    (15) 
























+ → HA + H+
Figure 60: Plot of experimental pKa1’s vs. theoretical ΔEaq’s. 
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n = 14, R2 = 0.962, s = 0.612, F = 304 
 
Again, the addition of the SM8 solvent model increased the coefficient of determination (R2 = 
0.962) significantly. The Fisher statistic is significantly larger here (F = 304) than observed in 
the model of pKa1 (F = 145) despite both models containing just one descriptor. In addition, a 
significant decrease in the standard deviation of the model was observed (s = 0.612). Statistical 
differences between these two models may be due to the uncertainty of experimental pKa1’s. 
Experimental pKa2’s may contain less uncertainty than pKa1’s because they are more widely 
studied due to their biological relevance.  
 
Figure 61: Plot of experimental pKa2’s vs. theoretical ΔEaq’s. 
 
These statistics indicated that ΔEAq is a very reliable molecular descriptor of experimental 
pKa’s. The pKa’s of similar heterocycles can most likely be accurately predicted using these 
computational models.  
■ An examination of Advanced Chemical Development’s pKa models 
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 As previously noted, the commercial program ACD employs a method that can be used 
to estimate a compound’s pKa. The merits of the ACD calculated pKa’s were assessed in the 
interest of further testing the computational models designed in this thesis. A linear regression 
was constructed to model the relationship between experimentally measured pKa1’s and ACD 
calculated pKa1’s (Figure 62) and the following linear regression and related statistics are shown 
in equation 16. 
                                   Pka1 (EXP.) = 1.07 (± 0.03) · Pka1 (ACD) + 0.34 (±0.2)                  (16) 
n = 19, R2 = 0.991, s = 0.334, F = 1583 
 
The correlation was large (R2 = 0.991) which indicates that the ACD computational model yields 
good results. The quality of this computational model was validated by the large Fisher statistic 
(F = 1583) and low standard deviation (s = 0.334).  
 
 
Figure 62: Plot of Experimental pKa1’s vs. ACD calc. pKa1’s. 
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A linear regression was also constructed to model the correlation between experimentally 
measured pKa2’s and ACD calculated pKa2’s (Figure 63) and the following linear regression and 
related statistics were obtained (equation 17): 
                                  pKa2 (exp) = 0.95 (± 0.05) · pKa1 (ACD) + 0.92 (±0.52)                   (17) 
n = 13, R2 = 0.966, s = 0.612, F = 316 
 
This model also yielded a high correlation coefficient (r2 = 0.996), the standard deviation of this 
model remained low (s = 0.612), but the Fisher statistic (F = 316) decreased significantly. These 
results suggest that ACD calculated pKa1’s have a slightly higher correlation with experimental 
pKa’s. This was an interesting finding because the computational models designed in this thesis 
correlated slightly better with experimentally determined pKa2’s.  
 
 
Figure 63: Plot of experimental pKa2’s vs. ACD calculated pKa2's.  
 
These results indicate that ACD calculated pKa’s are of comparable quality to those 
calculated by the theoretical models designed in this thesis. However, ACD calculated pKa’s are 
limited to compounds that contain only fragmented segments found in the company database. 
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Additionally, this study revealed that ACD calculated pKa’s only consider nitrogen acids while 
excluding other types, such as carbon acids. ACD also fails to identify the major tautomer, 
although they do list multiple tautomeric forms associated with a compound.   
■ Estimating pKa’s of compounds with previously unreported pKa’s 
 The pKa’s of compounds for which there was no previously reported literature value were 
estimated using the computational models developed in this study (Tables 14 and 15). The 
literature values shown in Tables 14 and 15 are averaged (when applicable) values taken from 
Table 12 and used in the linear regressions. The pKa1’s of uracil and its derivatives and also 
pyrrole were not estimated because calculations shown in Chapter 2 revealed that they act as 
carbon acids, and therefore their values would require a unique computational model. Oxazole 
and isoxazole were determined to be pKa1  outliers and were therefore omitted from the 
regression. The calculated pKa1’s for these two compounds are extremely negative, which may 
explain why they were outliers. For one thing, negative pKa’s can be difficult to measure. The 
estimated pKa2’s in this study appear to fall within reasonable ranges given the structures of the 








Table 14: Literature pKa1’s and estimated pKa1’s.  
Compound ΔE kJ/mol Exp. pKa1 Est. pKa1a Residuals 
azauracil -1084 - -9.38 - 
aziridine -1216 8.01 7.98 0.433 
creatinine -1188 4.8 4.21 0.019 
cytosine -1183 4.5 3.50 0.071 
flucytosine -1169 3.26 1.80 -0.062 
imidazole -1213 7.07 7.44 -0.123 
1-methylimidazole -1216 7.95 7.85 -0.299 
4-methylimidazole  -1215 7.55 7.65 0.198 
isocytosine -1183 4.01 3.55 -0.274 
isoxazole -1115 -2.0 -4.85 - 
maleimide -1035 - -15.81 - 
oxazole -872 0.8 -7.92 - 
piperidine  -1239 11.12 10.93 1.32 
piperazine -1226 9.76 9.17 1.31 
1-methylpiperazine -1231 10.19 9.84 0.277 
pyrazine -1166 0.65 1.38 -2.02 
pyrazole -1174 2.61 2.49 -0.939 
pyridazine  -1186 2.3 3.10 -1.46 
pyridine -1200 5.23 5.82 -0.751 
pyrimidine -1172 1.3 2.15 -1.94 
pyrrolidine -1239 11.71 10.90 1.49 
succinimide -1007 - -19.51 - 















Table 15: Literature pK2’s and estimated pKa2’s.  
Compound ΔE kJ/mol Exp. pKa2 Calc. pKa2b Residuals 
azauracil -1179 - 7.31 0.665 
aziridine -1325 - 28.97 - 
creatinine -1217 - 12.67 - 
cytosine -1216 12.57 12.39 0.0189 
isocytosine -1196 9.42 9.61 -0.224 
flucytosine -1910 - 11.70 - 
imidazole -1216 14.4 12.40 -0.148 
4-methylimidazole -1224 - 13.77 - 
maleimide -1196 9.5 9.63 -0.159 
piperazine -1313 - 34.67 - 
1-methylpiperazine -1395 - 37.69 - 
piperidine -1310 - 38.43 - 
pyrrole -1243 17.0 16.16 0.803 
pyrrolidine -1390 - 37.04 - 
thymine -1199 9.71 10.05 -0.391 
uracil -1200 9.44 10.18 -0.770 
5-bromouracil -1184 7.91 7.83 0.0463 
5-chlorouracil -1182 7.92 7.56 0.328 
fluorouracil -1193 7.99 9.15 -1.03 
5-formyluracil -1180 6.84 7.35 -0.546 
5-nitrouracil -1159 5.3 4.33 0.935 














  Below is the derivation of the Gibbs Energy of a mole of protons. This derivation was 
performed because Spartan’10 does not account for the Gibbs Energy of a proton. The molar 
Gibbs Energy was added to the theoretically calculated ΔG’s in order to achieve a more 
complete theoretical model. The derivation begins with the Gibbs Energy definition: 
                                                                  𝐺𝑜 = 𝐻𝑜 − 𝑇𝑆𝑜                                                   (1) 
 
The enthalpy H is equal to the sum of the internal energy and the product of the pressure and 
volume. 
                                                                   𝐻𝑜 = 𝑈 + 𝑃𝑉                                                    (2) 
 
The product of pressure and volume can be estimated from the ideal gas law, where the number 
of moles is equal to one. 
                                                                 𝑃𝑉 = 𝑛𝑅𝑇, 𝑛 = 1                                                 (3) 
 
The internal energy can be determined from the translational energy expression from the law of 
equipartition of energy for three degrees of motional freedom: 
                                                                      𝑈 =
3
2
(𝑅𝑇)                                                     (4) 
 





                                                         𝐻𝑜 =
3
2
(𝑅𝑇) + 𝑅𝑇 =
5
2
(𝑅𝑇)                                        (5) 
The entropy S of a mole of protons can be calculated using the Sakur-Tetrode equation. 
                                𝑆𝑜 = 1.5𝑅 𝑙𝑛(𝑀) + 2.5𝑅 ln(𝑇) − 1.1517𝑅 = 0.1089
𝑘𝐽
𝑚𝑜𝑙∗𝐾
              (6) 
 
                                           𝐺𝑜 =
5
2






                            (7) 
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